“Evaluation of Microbial Risk Factors in Relation to Clinical Effectiveness of Off-Label Bevacizumab Use for Retinal Disease Treatment: Research Article”. 2026. Pak-Euro Journal of Medical and Life Sciences 9 (1): 25-34. https://doi.org/10.31580/pjmls.v9i1.3417.